Vaccine Exemplars

The vaccine exemplar project is one in a series of exemplar projects funded by The Bill & Melinda Gates Foundation in conjunction with Gates Ventures. These exemplar projects showcase countries that have exceeded expectations in areas such as stunting, under five mortality, community health workers, and vaccination. We seek to identify and understand “exemplar” immunization programs at a national and subnational level which performed better than their peers in driving improvements in high and sustainable vaccine coverage. The goal of the vaccine exemplar project is to generate actionable recommendations to the foundation, its partners, and to the global health community at large. We have selected three countries with exemplary vaccine coverage – Senegal, Nepal, and India - and aim to show why and how these countries have succeeded in achieving significantly improved coverage rates.

This research will explore the catalysts, motivators, change management, and implementation success factors through a multidisciplinary approach. Partners in the Department of Political Science at Emory College; Goizueta Business School at Emory University; Rollins School of Public Health at Emory University; H. Milton Stewart School of Industrial and Systems Engineering at Georgia Institute of Technology (GA Tech); Scheller College of Business at GA Tech; and the School of Public Policy in Ivan Allen College of Liberal Arts at GA Tech provide a diverse viewpoint to assess exemplar status.

In the press:


Study Location

Senegal, Nepal, India, Zambia


Principal Investigators

Matthew Freeman, Robert Bednarczyk



Gates Ventures



Bill & Melinda Gates Foundation


Project Staff

Bonheur Dounebaine, Anna Ellis, Kyra Hester



Emory University: Miguel R. Rudea, Natália Salgado Bueno, B. Pablo Montagnes, Wesley Longhofer, Diwas KC, Benjamin Lopman, Walter A. Orenstein, Saad Omer, Cam Escoffery

Georgia Institute of Technology: Pinar Kesinocak, Kimberley Isett, L. Beril Toktay